The evolution of the regulatory framework for antibacterial agents
Author:
Affiliation:
1. AstraZeneca Pharmaceuticals Waltham Massachusetts
2. University of Texas Medical School‐Houston Houston Texas
3. AbbVie Rockville Maryland
4. Cubist Pharmaceuticals Lexington Massachusetts
5. AstraZeneca Pharmaceuticals Washington DC
Publisher
Wiley
Subject
History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/nyas.12441
Reference44 articles.
1. Anonymous.2013. Antibiotic resistance threats in the United States 2013.US Dept HHS Centers for Disease Control and Prevention.http://www.cdc.gov/drugresistance/threat‐report‐2013/. Accessed April 13 2014.
2. Anonymous.2009.The bacterial challenge: time to reach. European CDC/European Medicines Agency Joint Technical Report.http://www.ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?ID=199&List=4f55ad51‐4aed‐4d32‐b960‐af70113dbb90. Accessed April 13 2014.
3. 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
4. Approval and Withdrawal of New Antibiotics and other Antiinfectives in the U.S., 1980–2009
5. Stoking the antibiotic pipeline
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Challenges in the development of novel antibiotics;Antibiotics - Therapeutic Spectrum and Limitations;2023
2. Discovery of Novel UDP-N-Acetylglucosamine Acyltransferase (LpxA) Inhibitors with Activity against Pseudomonas aeruginosa;Journal of Medicinal Chemistry;2021-09-27
3. Medicinal Chemistry of β‐Lactam Antibiotics;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26
4. A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions;Journal of Medicinal Chemistry;2021-02-22
5. Mining Actinomycetes for Novel Antibiotics in the Omics Era: Are We Ready to Exploit This New Paradigm?;Antibiotics;2018-09-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3